Cargando…

Immunological combination treatment holds the key to improving survival in pancreatic cancer

Advances in surgery, peri-operative care and systemic chemotherapy have not significantly improved the prognosis of pancreatic cancer for several decades. Early clinical trials of immunotherapy have yielded disappointing results proposing other means by which the tumour microenvironment serves to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Sodergren, M. H., Mangal, N., Wasan, H., Sadanandam, A., Balachandran, V. P., Jiao, L. R., Habib, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519893/
https://www.ncbi.nlm.nih.gov/pubmed/32748119
http://dx.doi.org/10.1007/s00432-020-03332-5

Ejemplares similares